NCT04025229

Brief Summary

This interventional trial recruits women with endometrial cancer to participate in high intensity interval training (HIIT) prior to their standard of care surgery. The study will evaluate tissue and blood to determine if HIIT training has anti-cancer effects. P

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 18, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

September 23, 2019

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2024

Completed
12 months until next milestone

Results Posted

Study results publicly available

August 24, 2025

Completed
Last Updated

October 15, 2025

Status Verified

October 1, 2025

Enrollment Period

5 years

First QC Date

July 16, 2019

Results QC Date

June 25, 2025

Last Update Submit

October 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Proliferative Markers in Endometrium Before and After HIIT Exercises

    Change in Ki-67 proliferation values within the HIIT intervention group between the initial biopsy and the surgical biopsy. The percentage of tumor cells that are positive for Ki-67, indicating they are in the active phases of the cell cycle (not resting). Low Ki-67 (\<10-15%): Slower-growing tumor. Intermediate (15-30%): Moderately proliferative. High (\>30%): Fast-growing, potentially more aggressive.

    3 years

Study Arms (1)

HIIT exercise

EXPERIMENTAL

Participants will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery

Behavioral: HIIT exercise

Interventions

HIIT exerciseBEHAVIORAL

High intensity interval training (4 to 6 sessions) prior to surgery

HIIT exercise

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study recruits women with endometrial cancer
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a diagnosis of endometrial cancer who are to undergo hysterectomy and staging
  • Between 40-75 years old
  • Body mass index of 30-50 kg/m2
  • Endometrioid histology endometrial cancer
  • Presumed clinically early stage disease (disease confined to uterus only)
  • Have access to a Smart Phone
  • Have access to email
  • Agree to visit the exercise and sport science laboratory within 2 days of SOC visit for baseline testing if enrollment procedures cannot be done on the same day.
  • Agree to visit clinic 2 (+/-2wks) weeks after surgery for SOC follow-up and post surgery visit, or willing to return to exercise and sport science laboratory 2 (+/-2wks) weeks post-surgery

You may not qualify if:

  • Meets American College of Sports Medicine Guidelines for physical activity (150 minutes / week)
  • Currently doing HIIT
  • Hospitalization for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 3 months
  • Active diagnosis of psychosis or current uncontrolled substance abuse disorder
  • Insulin-dependent diabetes
  • Currently in another EC intervention
  • Severe dementia or other memory loss condition
  • Severe mental health disorder
  • Severely impaired hearing or speech
  • Inability to speak English
  • Musculoskeletal or neuromuscular condition that limits physical activity Any condition, in the opinion of the investigators, which would prohibit safe participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, 27599, United States

Location

MeSH Terms

Conditions

Endometrial Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Results Point of Contact

Title
Luz Andrea Cuaboy
Organization
UNC Lineberger Comprehensive Cancer Center

Study Officials

  • Victoria Bae-Jump, MD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Participants will complete HIIT training prior to surgery
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2019

First Posted

July 18, 2019

Study Start

September 23, 2019

Primary Completion

September 8, 2024

Study Completion

September 8, 2024

Last Updated

October 15, 2025

Results First Posted

August 24, 2025

Record last verified: 2025-10

Locations